Safety, Feasibility, and Patient Experience of Ten-Minute Pembrolizumab Infusions: A Prospective Cohort Study
Ten-minute pembrolizumab infusions are safe and well tolerated and enhance both patient satisfaction and outpatient efficiency.
Authors
- Elise J. Smolders (ORCID: https://orcid.org/0000-0001-5694-9758)
- Jan Gerard Maring (ORCID: https://orcid.org/0009-0009-8533-9233)
- Jan Willem B. de Groot (ORCID: https://orcid.org/0000-0002-1043-5011)
- Mireille A. Edens (ORCID: https://orcid.org/0000-0001-5449-5035)
- Dirk Jan A. R. Moes (ORCID: https://orcid.org/0000-0003-3219-253X)
- P. Plomp (ORCID: https://orcid.org/0009-0000-6640-9448)
- Helle-Brit Fiebrich-Westra
- Gijs M.M. Lenis
- Elianne C.S. de Boer (ORCID: https://orcid.org/0009-0002-4314-5106)
Institutions
- University Medical Center Groningen (NL)
- Leiden University Medical Center (NL)
- Isala (NL)
Publication Details
- Journal
- JCO Oncology Practice
- Published
- 2025-12-17
- DOI
- https://doi.org/10.1200/op-25-00918
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00